Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Functional Profiling of CFTR-Directed Therapeutics Using Pediatric Patient-Derived Nasal Epithelial Cell Models

Frontiers in Pediatrics(2020)10.3389/fped.2020.00536Source: DataRank Database

Functional Profiling of CFTR-Directed Therapeutics Using Pediatric Patient-Derived Nasal Epithelial Cell Models is a research paper published in Frontiers in Pediatrics (2020). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

omim

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.88)OA: goldTopics (59)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Anura Shrivastava,Chengkang Zhang ORCID,Brian A. Pollok,Walter E. Finkbeiner ORCID,Elizabeth R. Gibb

Live enrichment

PubMed:33014932 PMC:PMC7500161 OpenAlex:https://openalex.org/W3083645370

NIDDK NIH HHS

Grant: P30 DK072517

NHLBI NIH HHS

Grant: R43 HL144177

National Institutes of Health

Grant: 1R43HL144177-01

HLS-Applying EpiX™ technology to enable ex vivo theratyping using nasal brushing samples from CF patients

National Institutes of Health

Cystic Fibrosis Foundation

FWCI

0.88

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fped.2020.00536

publisherhttps://doi.org/10.3389/fped.2020.00536

publisherhttps://www.frontiersin.org/article/10.3389/fped.2020.00536/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33014932

repositoryhttps://doaj.org/article/b342a898442b4dfd9091236eb20315e6

Fields of Study

Cystic Fibrosis Research AdvancesCongenital Ear and Nasal Anomalies0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

Cystic fibrosisIvacaftorPotentiatorAmilorideCystic fibrosis transmembrane conductance regulatorMedicineMolecular biologyPharmacologyInternal medicineBiologyChemistrySodium3(21kb) (C.54-5940_270+10250del21 Kb406-1g->A (C.274-1g>A)C.850dupa (977insaCftrdele2F508del (C.1521_1523delcttMutation-Specific Cftr Function AnalysisP.Arg117his)P.Arg334trp)P.Met284asnfs)P.Phe508del)P.Ser18argfsx16)R117h-7t (C.350g>AR334w (C.1000c>T570Met284Asnfs)F508del (cp406-1G->A (c54-5940_270+10250del21 kbPediatricsRJ1-570618Paediatrics and Reproductive MedicineRare DiseasesR117H-7T (cR334W (cLungOther Medical and Health SciencesSer18ArgfsX16)Arg334Trp)350G>AArg117His)3(21kb) (cOrphan DrugGood Health and Well Beingc1000C>T1521_1523delCTT274-1G>A)Phe508del)406-1G->A850dupA (977insA

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Reduced inequalitiesSDG 0: Peace, Justice and strong institutions